Leadership - Lunatum Biotech, LLC - your preclinical CRO
Oliver B. Betz, PhD
Oliver is the Chief Executive Officer and founder of Lunatum Biotech, LLC - your preclinical CRO; he received post-doctoral training at Harvard Medical School and was an Instructor at the Center for Molecular Orthopedics; Oliver served as Head of Orthopedic Regenerative Medicine at the University of Munich LMU and was a Visiting Scientist at MIT; he has 25 + years of experience in musculoskeletal research and orthopedic gene medicine.
Volker M. Betz, MD
Volker is the Medical Director of Lunatum Biotech, LLC - your preclinical CRO; he received post-doctoral training at Harvard Medical School; Volker is an Orthopedic Surgeon and a passionate scientist; he has 20 + years of experience in preclinical musculoskeletal research and orthopedic gene therapy.
Fawzy A. Saad, PhD
Fawzy serves as Chief Scientific Officer at Lunatum Biotech, LLC - your preclinical CRO; he received post-doctoral training at Harvard Medical School and was an Assistant Professor at Einstein College of Medicine; Fawzy has 25 + years of experience in molecular musculoskeletal medicine.
ADVISORY BOARD - Lunatum Biotech, LLC - your preclinical CRO
Ellen Morgan
Ellen brings over 25 years of experience in drug development and CRO leadership. She founded and led Synteract and Agility Clinical, later serving as President, Rare Diseases at Precision for Medicine. With a proven track record in building and scaling CROs, optimizing trial strategies, and driving innovation, Ellen’s expertise in pharma and biotech makes her a valuable advisor to Lunatum Biotech.
Christian Thirion
Mari Anne Snow